NCT07887074

Brief Summary

Background Inadequate oral health can further compromise general health, particularly in elderly patients who are more susceptible to tooth loss, periodontal disease, and oral infections. These conditions can impair nutrition and overall well-being and are associated with increased risks of systemic diseases, underscoring the critical need for effective oral care in this population. Essential oils and various plant extracts have attracted considerable attention as potential natural medicinal products due to their proven antibacterial, antifungal, antiviral, and antioxidant properties. However, the precise effects and underlying mechanisms through which essential oil mouthwashes promote oral health remain incompletely understood. Objective This study aims to evaluate the potential of a mouthwash formulated with a blend of tea tree, lemon, and bay laurel essential oils, which have long been recognized for their medicinal properties in alleviating inflammatory signs of intraoral mucosa and promoting both oral and gingival health, in comparison with/ without alcohol-based mouthwashes. Methods One hundred five community-dwelling elderly individuals were randomly assigned to one of three groups and used a designated mouthwash for oral care over 21 days. The study groups were as follows:

  1. 1.Essential oils mouthwash (tea tree, lemon, and bay laurel).
  2. 2.Chlorhexidine alcohol-free mouthwash.
  3. 3.Povidone-iodine alcohol-free mouthwash. Participants were instructed to use the assigned mouthwash for oral hygiene at least twice daily, in the morning and evening. Saliva samples were collected on day 1 (before using the mouthwash) and on day 21 to analyze oral microbiota and inflammation markers and assess oral health and the incidence of upper respiratory tract infections.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 12, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 11, 2026

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 12, 2026

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

October 15, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

October 21, 2026

Completed
Last Updated

October 21, 2026

Status Verified

February 1, 2025

Enrollment Period

10 months

First QC Date

October 15, 2026

Last Update Submit

October 15, 2026

Conditions

Keywords

essential oiltea treemouthwashoral healthrespiratory infection

Outcome Measures

Primary Outcomes (3)

  • Change in Oral Health Assessment Tool (OHAT) Score

    Overall oral health status assessed by a trained assessor blinded to group allocation using the Oral Health Assessment Tool, which comprises eight domains (lips, tongue, gums and oral tissues, saliva, natural teeth, dentures, oral cleanliness, and dental pain), each scored 0-2. Total score ranges from 0 to 16; higher scores indicate poorer oral health.

    Baseline (Day 1) and Day 21

  • Change in Plaque Index Score

    Dental plaque accumulation assessed using a plaque-disclosing agent and scored by a trained assessor blinded to group allocation according to the Silness and Löe criteria: 0 = no plaque, 1 = thin film of plaque along the gingival margin, 2 = visible plaque accumulation, 3 = abundant plaque accumulation. Higher scores indicate greater plaque accumulation.

    Baseline (Day 1) and Day 21

  • Change in Halitosis Consequences Inventory (ICH) Score

    Halitosis-related quality of life assessed using the 18-item self-report Halitosis Consequences Inventory, with each item rated dichotomously for the presence (1) or absence (0) of the corresponding behavioral, emotional, or social consequence of bad breath. Total score ranges from 0 to 18; higher scores indicate greater perceived impact of halitosis.

    Baseline (Day 1) and Day 21

Secondary Outcomes (6)

  • Change in Stomatitis Index Score

    Baseline (Day 1) and Day 21

  • Change in Self-Perceived Oral Health Status

    Baseline (Day 1) and Day 21

  • Change in Geriatric Oral Health Assessment Index (GOHAI) Score

    Baseline (Day 1) and Day 21

  • Incidence of Upper Respiratory Tract Symptoms

    Baseline (Day 1) and Day 21

  • Change in Salivary Oral Microbiota Composition

    Baseline (Day 1) and Day 21

  • +1 more secondary outcomes

Study Arms (3)

Essential oil mouthwash

EXPERIMENTAL

Participants rinse with 30 mL of an alcohol-free mouthwash containing a blend of tea tree, lemon, and bay laurel essential oils for at least 30 seconds twice daily (morning and evening) after toothbrushing for 21 days.

Other: Essential oil mouthwash

Chlorhexidine Mouthwash

ACTIVE COMPARATOR

Community-dwelling older adults using an alcohol-free chlorhexidine mouthwash twice daily for 21 days.

Other: Chlorhexidine gluconate alcohol-free mouthwash

Povidone-Iodine Mouthwash

ACTIVE COMPARATOR

Community-dwelling older adults using an alcohol-free povidone-iodine mouthwash twice daily for 21 days.

Other: Povidone-iodine alcohol-free mouthwash

Interventions

Participants rinse with 30 mL of an alcohol-free mouthwash containing a blend of tea tree, lemon, and bay laurel essential oils for at least 30 seconds twice daily (morning and evening) after toothbrushing for 21 days.

Essential oil mouthwash

Participants rinse with 30 mL of an alcohol-free chlorhexidine gluconate 2.0 mg/mL mouthwash for at least 30 seconds twice daily (morning and evening) after toothbrushing for 21 days.

Chlorhexidine Mouthwash

Participants rinse with 30 mL of an alcohol-free povidone-iodine mouthwash (available iodine 1 mg/mL) for at least 30 seconds twice daily (morning and evening) after toothbrushing for 21 days.

Povidone-Iodine Mouthwash

Eligibility Criteria

Age65 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Aged 65 years or older.
  • Able to communicate verbally.
  • No history of asthma, eczema, or allergy to flowers or plants.
  • No known hypersensitivity to essential oils, chlorhexidine, or cetylpyridinium chloride.
  • No immunocompromising conditions.
  • No current use of antihistamines, immunosuppressants, biologic agents, disease-modifying antirheumatic drugs (DMARDs), or corticosteroids that may affect inflammatory responses.
  • Willing to participate in the study.
  • No use of essential oils or complementary medicine during the past week.

You may not qualify if:

  • Younger than 65 years of age.
  • Observation period of less than 30 days.
  • Major immunodeficiency disorder.
  • Dental treatment for periodontal disease or oral infection during the study period.
  • History of hypersensitivity to essential oils, chlorhexidine, or povidone-iodine.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

An Nan Hospital, China Medical University, Tainan, Taiwan.

Tainan, 709, Taiwan

Location

MeSH Terms

Conditions

Dental PlaqueRespiratory Tract Infections

Interventions

chlorhexidine gluconateEthanolPovidone-Iodine

Condition Hierarchy (Ancestors)

Dental DepositsTooth DiseasesStomatognathic DiseasesInfectionsRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

AlcoholsOrganic ChemicalsIodophorsIodine CompoundsInorganic ChemicalsPolyvinylsVinyl CompoundsAlkenesHydrocarbons, AcyclicHydrocarbonsPovidonePyrrolidinonesPyrrolidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPlasticsPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and Agriculture

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
Blocked randomization using a computer-generated list was performed because of the small sample size. One hundred fifty patients were recruited and allocated a ratio of 1:1:1 into one of the following three groups (n = 50 per group). Group A received mouthwash with essential oils (tea tree, lemon, and bay laurel). Group B received Chlorhexidine alcohol-free mouthwash, and Group C received Povidone-iodine alcohol-free mouthwash. A computer-generated list of random numbers using block randomization procedures was utilized to allocate participants.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The trial was conducted from January 1, 2025, to December 31, 2025, in the neighboring community areas of a regional teaching hospital in southern Taiwan. This study employed an examiner-blind, three-armed, randomized controlled trial design. Blocked randomization using a computer-generated list was performed because of the small sample size. One hundred fifty patients were recruited and allocated a ratio of 1:1:1 into one of the following three groups (n = 50 per group). Group A received mouthwash with essential oils (tea tree, lemon, and bay laurel). Group B received Chlorhexidine alcohol-free mouthwash, and Group C received Povidone-iodine alcohol-free mouthwash. A computer-generated list of random numbers using block randomization procedures was utilized to allocate participants.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 15, 2026

First Posted

October 21, 2026

Study Start

April 12, 2025

Primary Completion

February 11, 2026

Study Completion

October 12, 2026

Last Updated

October 21, 2026

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be made publicly available because the dataset contains health information from community-dwelling older adults that could compromise participant privacy and confidentiality, and the informed consent obtained did not include provision for public data sharing. De-identified data supporting the published findings may be made available from the corresponding author upon reasonable request, subject to approval by the Institutional Review Board of An Nan Hospital, China Medical University, and in compliance with applicable data protection regulations and institutional data governance policies.

Locations